These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 38051365)

  • 1. Antibiofilm activity of mesoporous silica nanoparticles against the biofilm associated infections.
    Sil M; Mukherjee D; Goswami A; Nag M; Lahiri D; Bhattacharya D
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3617-3633. PubMed ID: 38051365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesoporous silica nanoparticles as diagnostic and therapeutic tools: how can they combat bacterial infection?
    Şen Karaman D; Manner S; Rosenholm JM
    Ther Deliv; 2018 Mar; 9(4):241-244. PubMed ID: 29495945
    [No Abstract]   [Full Text] [Related]  

  • 3. Polyethylenimine-grafted mesoporous silica nanocarriers markedly enhance the bactericidal effect of curcumin against Staphylococcus aureus biofilm.
    Pamukçu A; Erdoğan N; Şen Karaman D
    J Biomed Mater Res B Appl Biomater; 2022 Nov; 110(11):2506-2520. PubMed ID: 35735075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quorum sensing inhibitors as anti-biofilm agents.
    Brackman G; Coenye T
    Curr Pharm Des; 2015; 21(1):5-11. PubMed ID: 25189863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme-Functionalized Mesoporous Silica Nanoparticles to Target
    Devlin H; Fulaz S; Hiebner DW; O'Gara JP; Casey E
    Int J Nanomedicine; 2021; 16():1929-1942. PubMed ID: 33727807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Stimuli-Responsive Mesoporous Silica Nanoparticles for Bacterial Infection Treatment.
    Colilla M; Vallet-Regí M
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33203098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Aspects of the Functioning of Pathogenic Bacteria Biofilm Based on
    Juszczuk-Kubiak E
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial and antibiofilm activities of meropenem loaded-mesoporous silica nanoparticles against carbapenem-resistant
    Memar MY; Yekani M; Ghanbari H; Nabizadeh E; Vahed SZ; Dizaj SM; Sharifi S
    J Biomater Appl; 2021 Oct; 36(4):605-612. PubMed ID: 33722086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox/pH dual-controlled release of chlorhexidine and silver ions from biodegradable mesoporous silica nanoparticles against oral biofilms.
    Lu MM; Ge Y; Qiu J; Shao D; Zhang Y; Bai J; Zheng X; Chang ZM; Wang Z; Dong WF; Tang CB
    Int J Nanomedicine; 2018; 13():7697-7709. PubMed ID: 30538453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supramolecular Assemblies of Heterogeneous Mesoporous Silica Nanoparticles to Co-deliver Antimicrobial Peptides and Antibiotics for Synergistic Eradication of Pathogenic Biofilms.
    Yu Q; Deng T; Lin FC; Zhang B; Zink JI
    ACS Nano; 2020 May; 14(5):5926-5937. PubMed ID: 32310641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tailoring Nanoparticle-Biofilm Interactions to Increase the Efficacy of Antimicrobial Agents Against
    Fulaz S; Devlin H; Vitale S; Quinn L; O'Gara JP; Casey E
    Int J Nanomedicine; 2020; 15():4779-4791. PubMed ID: 32753866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesoporous Silica-Based Materials with Bactericidal Properties.
    Bernardos A; Piacenza E; Sancenón F; Hamidi M; Maleki A; Turner RJ; Martínez-Máñez R
    Small; 2019 Jun; 15(24):e1900669. PubMed ID: 31033214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combating bacterial biofilms and related drug resistance: Role of phyto-derived adjuvant and nanomaterials.
    Kungwani NA; Panda J; Mishra AK; Chavda N; Shukla S; Vikhe K; Sharma G; Mohanta YK; Sharifi-Rad M
    Microb Pathog; 2024 Oct; 195():106874. PubMed ID: 39181190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facile Synthesis of Three Types of Mesoporous Silica Microspheres as Drug Delivery Carriers and their Sustained-Release Properties.
    Zhu Y; Wang B; Chen J; He J; Qiu X
    Curr Drug Deliv; 2023; 20(9):1337-1350. PubMed ID: 35713141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Nanotherapeutics as Next-generation Anti-infective Agents: Current Trends and Future Prospectives.
    Subhaswaraj P; Syed A; Siddhardha B
    Curr Drug Discov Technol; 2020; 17(4):457-468. PubMed ID: 31309893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Strategies to Combat Bacterial Biofilms.
    Hemmati F; Rezaee MA; Ebrahimzadeh S; Yousefi L; Nouri R; Kafil HS; Gholizadeh P
    Mol Biotechnol; 2021 Jul; 63(7):569-586. PubMed ID: 33914260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversity of Bacteria and Bacterial Products as Antibiofilm and Antiquorum Sensing Drugs Against Pathogenic Bacteria.
    Khan F; Oloketuyi SF; Kim YM
    Curr Drug Targets; 2019; 20(11):1156-1179. PubMed ID: 31020938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesoporous silica nanoparticles decorated with polycationic dendrimers for infection treatment.
    González B; Colilla M; Díez J; Pedraza D; Guembe M; Izquierdo-Barba I; Vallet-Regí M
    Acta Biomater; 2018 Mar; 68():261-271. PubMed ID: 29307796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesoporous Silica Nanoparticles: Drug Delivery Vehicles for Antidiabetic Molecules.
    Sarkar S; Ekbal Kabir M; Kalita J; Manna P
    Chembiochem; 2023 Apr; 24(7):e202200672. PubMed ID: 36719179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Perspectives on the Use of Phytochemicals as an Emergent Strategy to Control Bacterial Infections Including Biofilms.
    Borges A; Abreu AC; Dias C; Saavedra MJ; Borges F; Simões M
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27399652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.